HIG’s Concord acquires Evolytics
HIG Capital (HIG), a global alternative investment firm with USD48 billion of equity capital under management, is pleased to announce that its portfolio company. Concord USA (Concord), a portfolio company of HIG Capital (HIG), has acquired Evolytics (Evolytics), it’s second add-on acquisition this year. Headquartered in Kansas City, Missouri, Evolytics